An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Danny R Welch Yibin Kang Ann F. Chambers Kazuyuki Itoh Jonathan P. Sleeman Erik W. Thompson Robin L Anderson Patricia Steeg |
| Publication date | July 1, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |